Vlado Štimac
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vlado Štimac.
Bioorganic & Medicinal Chemistry | 2010
Maja Matanović Škugor; Vlado Štimac; Ivana Palej; Đurdjica Lugarić; Hana Čipčić Paljetak; Darko Filic; Marina Modrić; Ivica Đilović; Dubravka Gembarovski; Stjepan Mutak; Vesna Eraković Haber; David J. Holmes; Zrinka Ivezić-Schoenfeld; Sulejman Alihodžić
The synthesis and antimicrobial activity of a new class of macrolide antibiotics which consist of a macrolide scaffold and a quinolone unit covalently connected by an appropriate linker are described. Optimization of several synthetic steps and structural properties of lead compound 26 are discussed. Promising antibacterial properties of this compound and some of its analogues are reported.
The Journal of Antibiotics | 2006
Sulejman Alihodzic; Andrea Fajdetić; Gabrijela Kobrehel; Gorjana Lazarevski; Stjepan Mutak; Drazen Pavlovic; Vlado Štimac; Hana Cipcic; Miroslava Dominis Kramarić; Vesna Eraković; Andreja Hasenöhrl; Nataša Maršić; Wolfgang Schoenfeld
A series of 3-keto and 3-O-acyl derivatives of both 6-O-alkyl-8a-aza-8a-homoerythromycin A and 6-O-alkyl-9a-aza-9a-homo-erythromycin A were synthesised and tested against Gram-positive and Gram-negative bacteria. Derivatives of 8a-aza-8a-homoerythromycin A have potent antibacterial activity against not only azithromycin-susceptible strains, but also efflux (M) and inducible macrolide-lincosamide-streptogramin (iMLSB) resistant Gram-positive pathogens, while the corresponding 9a-isomers were less active. Introduction of an additional ring such as 11,12-cyclic carbonate reduced antibacterial activity of both series. 3-Keto and 3-O-(4-nitrophenyl)acetyl derivatives of 6-O-methyl-8a-aza-8a-homo-erythromycin A show typical macrolide pharmacokinetics in preliminary in vivo studies in mice, and their in vivo efficacy is demonstrated.
Bioorganic & Medicinal Chemistry | 2011
Samra Kapić; Hana Čipčić Paljetak; Ivana Palej Jakopović; Andrea Fajdetić; Marina Ilijaš; Vlado Štimac; Karmen Brajša; David J. Holmes; John M. Berge; Sulejman Alihodžić
Three macrolides, clarithromycin, azithromycin and 11-O-Me-azithromycin have been selected for the construction of a series of new macrolone derivatives. Quinolone-linker intermediates are prepared by Sonogashira-type C(6)-alkynylation of 6-iodoquinolone precursors. The final macrolones, differing by macrolide moiety and substituents at the position N-1 of the quinolone or by the presence of an ethyl ester or free acid on the quinolone unit attached via a linker. The linker comprises of a central piperazine ring bonded to the 4″-O position of cladinose by 3-carbon ester or ether functionality. Modifications of the linker did not improve antibacterial properties compared to the previously reported macrolone compounds. Linker flexibility seems to play an important role for potency against macrolide resistant respiratory pathogens.
Bioorganic & Medicinal Chemistry Letters | 2012
Ivana Palej Jakopović; Mirjana Bukvić Krajačić; Maja Matanović Škugor; Vlado Štimac; Dijana Pesic; Ines Vujasinović; Sulejman Alihodžić; Hana Čipčić Paljetak; Goran Kragol
Novel modifications of the desosamine sugar of 14- and 15-membered antibacterial macrolides, in which the desosamine was fused with N-substituted-1,3-oxazolidin-2-ones, were developed in order to completely suppress antibacterial activity and make them promising agents for other biological targets. The synthesis of such bicyclic desosamine derivatives, especially 1,3-oxazolidin-2-one formation, was optimized and conducted under mild conditions without a need for protection/deprotection steps for other functional groups. A focused series of novel desosamine-modified macrolide derivatives was prepared and their antibacterial activities tested. It was shown that these macrolide derivatives do not possess any residual antibacterial activity.
The Journal of Antibiotics | 2009
Vlado Štimac; Sulejman Alihodzic; Gorjana Lazarevski; Stjepan Mutak; Zorica Marušić Ištuk; Andrea Fajdetić; Ivana Palej; Hana Čipčić Paljetak; Jasna Padovan; Branka Tavčar; Vesna Eraković Haber
A series of 4″-O-acyl derivatives of 8a-aza-8a-homoerythromycins A were synthesized and tested against Gram-positive and Gram-negative bacteria. Derivatives of 8a-aza-8a-homoerythromycin A have potent anti-bacterial activity against not only azithromycin-susceptible strains, but also efflux (M) and inducible macrolide–lincosamide–streptogramin-resistant Gram-positive pathogens. These compounds show moderate to high clearance and low oral bioavailability in preliminary in vivo pharmacokinetic studies in rat.
Bioorganic & Medicinal Chemistry | 2010
Andreja Fajdetić; H. Čipčić Paljetak; Gorjana Lazarevski; Antun Hutinec; Sulejman Alihodžić; Marko Đerek; Vlado Štimac; D. Andreotti; Vitomir Šunjić; John M. Berge; Stjepan Mutak; Miljenko Dumic; S. Lociuro; David J. Holmes; Nataša Maršić; V. Eraković Haber; Radan Spaventi
Bioorganic & Medicinal Chemistry | 2010
Ivana Palej Jakopović; Goran Kragol; Andrew Keith Forrest; Catherine Simone Victoire Frydrych; Vlado Štimac; Samra Kapić; Maja Matanović Škugor; Marina Ilijaš; Hana Čipčić Paljetak; Dubravko Jelić; David J. Holmes; Deirdre Mary Bernadette Hickey; Donatella Verbanac; Vesna Eraković Haber; Sulejman Alihodžić
Archive | 2006
Sulejman Alihodzic; Drazen Pavlovic; Eric Hunt; Andrew Keith Forrest; Ivana Palej; Samra Kapić; Vlado Štimac
Synthesis | 2010
Adrijana Vinter; Amir Avdagić; Vlado Štimac; Ivana Palej; Ana Čikoš; Vitomir Šunjić; Sulejman Alihodzic
Organic Process Research & Development | 2010
Vlado Štimac; Maja Matanović-Škugor; Palej Jakopović Ivana; Adrijana Vinter; Marina Ilijaš; Sulejman Alihodžić; Stjepan Mutak